Peer Review reports
From: Real-world evidence on the economic implications of CGRP-mAbs as preventive treatment of migraine
| Original Submission | ||
|---|---|---|
| 26 Sep 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 24 Feb 2023 | Reviewed | Reviewer Report |
| 29 Mar 2023 | Reviewed | Reviewer Report |
| 1 May 2023 | Reviewed | Reviewer Report |
| 25 May 2023 | Author responded | Author comments - Nikolaj Siersbæk |
| Resubmission - Version 3 | ||
| 25 May 2023 | Submitted | Manuscript version 3 |
| 18 Jun 2023 | Reviewed | Reviewer Report |
| 18 Jun 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 22 Jun 2023 | Editorially accepted | |
| 3 Jul 2023 | Article published | 10.1186/s12883-023-03302-7 |
You can find further information about peer review here.